Afrezza (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the Afrezza drug offered from Sanofi-Aventis U.S. LLC. This Insulin [Chemical/Ingredient],Insulin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Insulin Human |
| SUBSTANCE NAME: | INSULIN HUMAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin [EPC] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER, METERED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-07-11 |
| END MARKETING DATE: | 0000-00-00 |
Afrezza HUMAN PRESCRIPTION DRUG Details:
| Item Description | Afrezza from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(1-Jan) |
| START MARKETING DATE: | 2014-07-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5874_596bfcee-8076-4cb8-a100-317f23c3c570 |
| PRODUCT NDC: | 0024-5874 |
| APPLICATION NUMBER: | NDA022472 |
Other INSULIN HUMAN Pharmaceutical Manufacturers / Labelers:
